GlassScriptPhysician profile
Casey Halpern
NPI 1710185525
$185,693.12
in general payments reported to CMS, 2019-2025
13 companies · $33K in 2025
The $33K reported for 2025 was more than what 93% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $28K · 2021: $10K · 2022: $36K · 2023: $21K · 2024: $20K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Travel and Lodging: $7,285 · Food and Beverage: $7,104 · Consulting Fee: $6,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,550.00 |
| Travel and Lodging | $7,285.31 |
| Food and Beverage | $7,104.23 |
| Consulting Fee | $6,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $155,491.12 | 2019-2025 | Vercise, General - Dbs, General - Therapies |
| Medtronic, INC. | $6,608.81 | 2021-2025 | Percept PC Brainsense, Activa PC |
| Insightec,INC | $6,221.39 | 2022-2025 | Exablate |
| Neuropace, INC. | $5,706.73 | 2019-2021 | |
| Medtronic USA, INC. | $5,241.16 | 2019 | |
| Abbott Laboratories | $3,604.60 | 2019-2025 | Infinity |
| Clearpoint Neuro, INC. | $2,500.00 | 2020 | |
| Zap Surgical Systems, INC. | $131.05 | 2019 | |
| Mdd US Operations, LLC | $83.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $77.35 | 2019 | |
| Baxter Healthcare | $27.61 | 2025 | Perclot |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Halpern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.